Conjugation of von Willebrand factor-binding domain of platelet glycoprotein Ibα to size-controlled albumin microspheres

Biomacromolecules

Volumn 1, Issue 2, 2000, Pages 290-295

  Takeoka, Shinji ^a   Teramura, Yuji ^a   Ohkawa, Haruki ^a   Ikeda, Yasuo ^b   Tsuchida, Eishun ^a  

^a WASEDA UNIVERSITY   (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CROSS LINKING REAGENT; CYTOCHROME C; MICROSPHERE; RECOMBINANT PROTEIN; SERUM ALBUMIN; THROMBIN RECEPTOR; VON WILLEBRAND FACTOR;

ARTICLE; CELL MEMBRANE; CHEMISTRY; DRUG DELIVERY SYSTEM; GEL CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; PROTEIN BINDING; THROMBOCYTE; ULTRAVIOLET SPECTROPHOTOMETRY;

BLOOD PLATELETS; CELL MEMBRANE; CHROMATOGRAPHY, GEL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CROSS-LINKING REAGENTS; CYTOCHROME C GROUP; DRUG DELIVERY SYSTEMS; HUMANS; MICROSPHERES; PLATELET GLYCOPROTEIN GPIB-IX COMPLEX; PROTEIN BINDING; RECOMBINANT PROTEINS; SERUM ALBUMIN; SPECTROPHOTOMETRY, ULTRAVIOLET; VON WILLEBRAND FACTOR;

EID: 0034209259     PISSN: 15257797     EISSN: None     Source Type: Journal    
DOI: 10.1021/bm0055293     Document Type: Article

References (31)

1. Fraley, R.; Straubinger. R. M.; Rule. G.; Spinger. E. L.; Papahadjopoulos. D. Liposome-mediated delivery of deoxyribonucleic acid to cells: enhanced efficiency of delivery related to lipid composition and incubation conditions. Biochemistry 1981, 20, 6978-6987.
2. Urdal. D. L.; Hakomori. S. Tumor-associated Ganglio-N-triosyl-ceramide. J. Biol. Chem. 1980, 255, 10509-10516.
3. Blume, G.;, Cevc, G.; Crommelin, M. D. J. A.; Bakker-Woudenberg, I. A. J. M.; Kluft, C.; Storm, G. Specific targeting with poly(ethylene glycol)-modified liposomes: coupling of homing devices to the ends of the polymeric chains combines effective target binding with long circulation times. Biochim. Biophys. Acta 1993, 1149, 180-184.
4. Allen, T. M.; Brandies, E.; Hansen, C. B.; Kao, G. Y.; Zalipsky, S. A new strategy for attachment of antibodies to sterically stabilized liposomes resulting in efficient targeting to cancer cells. Biochim. Biophys. Acta 1995, 1237, 99-108.
5. Ansell, S. M.; Tardi, P. G.; Buchkowsky. S. S. 3-(2-Pyridlydithio)-propionic acid hydrazide as a cross-linker in the formation of liposome-antibody conjugates. Bioconjugate Chem. 1996, 7, 490-496.
6. Martin. F. J.; Hubbell, W. L.; Papahadjopoulos, D. Immunospecific targeting of liposomes to cells: a novel and efficient method for covalent attachment of Fab' fragments via disulfide bonds. Biochemistry 1981, 20, 4229-4238.
7. Bendas, G.; Vogel, J.; Bakowski, U.; Krause, A.; Muller, J.; Rothe, U. A liposome-based model system for the simulation of lectin-induced cell adhesion. Biochim. Biophys. Acta 1997, 1325, 297-308.
8. Yokomaya, M.; Kwon, G. S. M.; Okano, T.; Sakurai, Y.; Seto, T.; Kataoka, K. Preparation of micelle-forming polymer-drug conjugates. Bioconjugate Chem. 1992, 3, 295-301.
9. Rajaonarivony. M.; Vauthier, C.; Couarraze, G.; Puisieux, F.; Couvreur, P. Development of a new drug carrier made from alginate. J. Pharm. Sci. 1993, 82, 912-917.
10. Modena, T.; Conti, B.; Genta, I.; Pauanetto, F.; Tira, M. E.; Sini, P.; Gazzaniga, A. Hyaluronidase-injectable microparticles intended for the treatment of extravasation. J. Microencapsulation 1998, 15, 85-92.
11. Truong-Le, V. L.; Walsh, S. M.; Schweibert, E.; Mao, H. Q.; Guggino, W. B.; August, J. T.; Leong, K. W. Gene transfer by DNA-gelatin nanospheres. Arch. Biochem. Biophys. 1999, 361, 47-56.
12. Blunk, T.; Hochstrasser, D. F.; Sanchez, J. C.; Muller, B. W.; Muller, R. H. Colloidal carriers for intravenous drug targeting: plasma protein adsorption patterns on surface-modified latex particles evaluated by two-dimensional polyacrylamide gel electrophoresis. Electrophoresis 1993, 14, 1382-1387.
13. Tang, M. X.; Redemann. C. T.; Szoka., F. C., Jr. In vitro gene delivery by degraded polyamidoamine dendrimers. Bioconjugate Chem. 1996, 7, 703-714.
14. Singh, P. Terminal groups in starburst dendrimers: activation and reactions with proteins. Bioconjugate Chem. 1998, 9, 54-63.
15. Hansen, C. B.; Kao, G. Y.; Moase, E. H.; Zalipsky, S.; Allen, T. M. Attachment of antibodies to sterically stabilized liposomes: Evaluation, comparison and optimization of coupling procedures. Biochim. Biophys. Acta 1995, 1239, 133-144.
16. Klibanov, A. L.; Maruyama, K.; Beckerleg, A. M.; Torchilin, V. P.; Huang, L. Activity of amphipatic poly(ethylene glycol) 5000 to prolong the circulation time of liposomes depends on the liposome size and is unfavorable for immunoliposome binding to target. Biochim. Biophys. Acta 1991, 7062, 142-148.
17. Phillips, W. T.; Klipper, R. W.; Awasthi, V. D.; Rudolph. A. S.; Cliff, R.; Kwasiborski, V.; Goins, B. A. Poly(ethylene glycol)-modified liposome-encapsulated hemoglobin: a long circulating red cell substitute. J. Pharmacol. Exp. Ther. 1999, 288, 665-670.
18. Hashida, S.; Hashinaka, K.; Ishikawa, S.; Ishikawa, E. More reliable diagnosis of infection with human immunodeficiency virus type 1 (HIV-1) by detection of antibody IgGs to pol and gag proteins of HIV-1 and p24 antigen of HIV-1 in urine, saliva, and/or serum with highly sensitive and specific enzyme immunoassay (immune complex transfer enzyme immunoassay): a review. J. Clin. Lab. Anal. 1997, 11, 267-28.
19. Marchese, P.; Saldivar. E.; Ware. J.; Ruggeri, Z. M. Adhesive properties of the isolated amino-terminal domain of platelet glycoprotein Ibα in a flow field. Proc. Natl. Acad. Sci. U.S.A. 96, 7837-7842.
20. Gupta. P. K.; Hung. C. T. Albumin microsphere I: physicochemical characteristics. J. Microencapsulation 1989, 6, 427-462.
21. Gupta. P. K.; Hung. C. T. Albumin microsphere II: applications in drug delivery. J. Microencapsulation 1989, 6, 463-472.
22. Carlsson, J.; Drevin, H.; Alex, R. Protein Thiolation and Reversible Protein-Protein conjugation. N-Succinimidyl 3-(2-pyridyldithio)-propionate, a new heteronifunctional reagent. Biochem. J. 1978, 173, 723-737.
23. Murata, M.; Ware, J.; Ruggeri. Z. M. Site-directed mutagenesis of a soluble recombinant fragment of platelet glycoprotein Iba demonstrating negatively charged residues involved in von Willebrand factor binding. J. Biol. Chem. 1991, 266, 15474-15480.
24. Kitaguchi, T.; Murata, M.; Iijima, K.; Kamide, K.; Imagawa, T.; Ikeda, Y. Characterization of liposomes carrying von Willebrand factor-binding domain of platelet glycoprotein Ibα: A potential substitute for platelet transfusion. Biochem. Biophys. Res. Commun. 1999, 267, 784-789.
25. Ozaki, Y.; Satoh, K.; Yatomi, Y.; Yamamoto. T.; Shirasawa. Y.; Kume, S. Detection of platelet aggregates with a particle counting method using light scattering. Anal. Biochem. 1994, 218, 284-294.
26. Peters, T., Jr. All about albumin: biochemistry, genetics, and medical applications; Academic Press: San Diego, CA, 1996; pp 9-23.
27. Huggins, C.; Tapley, D. P.; Jensen. E. J. Sulphydryl-disulphide relationships in the induction of gels in proteins by urea. Nature 1951, 167, 592-593.
28. Warner, C. R.; Levy, M. Denaruration of bovine Plasma albumin. II. Isolation of intermediates and mechanism of the reaction at pH 7. J. Am. Chem. Soc. 1958, 80, 5735-5744.
29. Grassetti, D. R.; Murray. Jr., J. F. Determination of sulfhydryl groups with 2. 2′-or 4, 4′-dithiodipyridine. Arch. Biochem. Biophys. 1967, 119, 41-49.
30. Singh, V.; Curtiss, R., 3rd. Effect of amino group modification of ovine luteinizing hormone (oLH) by N-Succinimidyl 6-[3-(2-pyridyldithio)propionate] hexanate, a long chain N-Succinimidyl 3-(2-pyridyldithio)propionate (SPDP) on immunological and biological properties: a comparative study with SPDP modified oLH, Mol. Cell. Biochem. 1994, 130, 83-90.
31. Na, D. H.; Woo. B. H.; Lee, K. C. Quantitative analysis of derivatized proteins prepared with pyridyl disulfide-containing cross-linkers by high-performance liquid chromatography. Bioconjugate Chem. 1999, 10, 306-310.